IDXG Interpace Biosciences


Data from SEC filings
Employee count

Shareholder alignment

Proxy contests and exempt solicitations in last 3 years

No recent proxy contest or exempt solicitation filings from shareholders.

Vote support at last AGM

On November 8, 2021, Interpace Biosciences, Inc. (the “Company”) held its 2021 annual meeting of stockholders (the “2021 Annual Meeting”). The following proposal was voted on and was approved by the Company’s stockholders at the 2021 Annual Meeting with the stockholders having voted as set forth below:

I.To ratify the appointment of BDO USA, LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2021.